Solving lung cancer inequality | Sponsored
The Politics Show
The New Statesman
4.2 • 1.5K Ratings
🗓️ 1 November 2023
⏱️ 32 minutes
🧾️ Download transcript
Summary
Lung cancer is the leading cause of cancer-related deaths worldwide – but it doesn't affect everyone equally.
Data shows wide regional variation of lung cancer diagnoses, as well as huge differentials linked to socio-economic factors and class.
In this episode Becky Slack is joined by a panel including a leading clinical expert, Professor David Baldwin, Lorraine Dallas from the Roy Castle Lung Cancer Foundation, as well as David Long from the leading pharmaceuticals company and our sponsor for this episode, MSD.
They discuss the root of lung cancer inequalities and how they can be mitigated.
This episode has been fully funded by MSD, one of the world's leading pharmaceutical companies active in several key areas of global health, including immunisation and oncology. Learn more about the work they do following the science to tackle some of the world's greatest health threats at www.msd.com
Listen to all our Spotlight on Policy episodes here: https://podfollow.com/spotlight-on-policy-from-the-new-statesman
LISTEN AD-FREE:
📱Download the New Statesman app
MORE FROM THE NEW STATESMAN:
❓ Ask a question – we answer them every Friday
⏰ Get our daily politics newsletter every morning
✍️ Enjoy the best of our writing via email every Saturday
Hosted on Acast. See acast.com/privacy for more information.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | The New Statesman |
| 0:02.0 | Statesman. |
| 0:03.0 | Hello and |
| 0:05.0 | Hello and |
| 0:08.0 | and Hello and welcome to this special podcast brought to you by the New Statesman's |
| 0:15.9 | Spotlight team. We cover policy for those who shape it and the businesses it affects. |
| 0:20.8 | I'm Becky Slack. In this episode, we're discussing a vital issue that affects tens of thousands of people every year and the poorest, worst, lung cancer. |
| 0:37.0 | November is officially Lung Cancer Awareness Month. |
| 0:40.0 | There are around 48,000 new cases of lung cancer every year in the UK. |
| 0:44.0 | It's the third most common form of cancer and in 2020 it was the leading form of cancer death worldwide. |
| 0:50.0 | But it doesn't affect everyone equally. |
| 0:53.0 | Incident rates are far higher among the most deprived groups of people in the UK, |
| 0:57.0 | and there is too often a post-code lottery when it comes to diagnosis. |
| 1:01.0 | Lung cancer is generally less survivable than other forms of cancer, so early diagnosis |
| 1:06.0 | is vital. |
| 1:07.0 | Over the next 20 minutes or so, I'm going to explore the reasons behind these inequalities |
| 1:12.2 | and what can be done about it with a panel of esteemed expert |
| 1:15.5 | guests. |
| 1:16.4 | This episode has been fully funded by MSD, one of the world's leading pharmaceutical companies, |
| 1:28.5 | who are active in several key areas of global health, including immunization and oncology. |
| 1:34.8 | Joining me from MSD is David Long, director of the Business Oncology Unit. |
| 1:39.9 | Also on the panel we have Lorraine Dallas, Director of Information Prevention and Support at Roy |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The New Statesman, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The New Statesman and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.